Intraventricular Gadoteric Acid Intoxication: First Report
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 111, 264-268
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast AgentsInvestigative Radiology, 2016
- Adverse Reactions to Gadoterate MeglumineInvestigative Radiology, 2016
- Non-clinical safety assessment of gadoterate meglumine (Dotarem®) in neonatal and juvenile ratsRegulatory Toxicology and Pharmacology, 2015
- Safety and efficacy of gadoteric acid in pediatric magnetic resonance imaging: overview of clinical trials and post-marketing studiesPediatric Radiology, 2015
- Dialysability of Gadoteric Acid in Patients With End-Stage Renal Disease Undergoing HemodialysisInvestigative Radiology, 2014
- Tolerability and diagnostic value of gadoteric acid in the general population and in patients with risk factors: Results in more than 84,000 patientsEuropean Journal of Radiology, 2012
- Gd-DOTA administration at MRI in children younger than 18 months of age: immediate adverse reactionsPediatric Radiology, 2011
- Neurotoxic Manifestations of an Overdose Intrathecal Injection of Gadopentetate DimeglumineJournal of Korean Medical Science, 2010
- Overdosage of intrathecal gadolinium and neurological responseClinical Radiology, 2008